P0C605 (KGP1_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 47.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: cGMP-dependent protein kinase 1 Short name=cGK 1 Short name=cGK1 EC=2.7.11.12 Alternative name(s): cGMP-dependent protein kinase I Short name=cGKI | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus |
Protein attributes
| Sequence length | 671 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Serine/threonine protein kinasethat acts as key mediator of the nitric oxide (NO)/cGMP signaling pathway. GMP binding activates PRKG1, which phosphorylates serines and threonines on many cellular proteins. Numerous protein targets for PRKG1 phosphorylation are implicated in modulating cellular calcium, but the contribution of each of these targets may vary substantially among cell types. Proteins that are phosphorylated by PRKG1 regulate platelet activation and adhesion, smooth muscle contraction, cardiac function, gene expression, feedback of the NO-signaling pathway, and other processes involved in several aspects of the CNS like axon guidance, hippocampal and cerebellar learning, circadian rhythm and nociception. Smoth muscle relaxation is mediated through lowering of intracellular free calcium, by desensitization of contractile proteins to calcium, and by decrease in the contractile state of smooth muscle or in platelet activation. Regulates intracellular calcium levels via several pathways: phosphorylates MRVI1/IRAG and inhibits IP3-induced Ca2+ release from intracellular stores, phosphorylation of KCNMA1 (BKCa) channels decreases intracellular Ca2+ levels, which leads to increased opening of this channel. PRKG1 phosphorylates the canonical transient receptor potential channel (TRPC) family which inactivates the associated inward calcium current. Another mode of action of NO/cGMP/PKGI signaling involves PKGI-mediated inactivation of the Ras homolog gene family member A (RhoA). Phosphorylation of RHOA by PRKG1 blocks the action of this protein in myriad processes: regulation of RHOA translocation; decreasing contraction; controlling vesicle trafficking, reduction of myosin light chain phosphorylation resulting in vasorelaxation. Activation of PRKG1 by NO signaling alters also gene expression in a number of tissues. In smooth muscle cells, increased cGMP and PRKG1 activity influence expression of smooth muscle-specific contractile proteins, levels of proteins in the NO/cGMP signaling pathway, down-regulation of the matrix proteins osteopontin and thrombospondin-1 to limit smooth muscle cell migration and phenotype. Regulates vasodilator-stimulated phosphoprotein (VASP) functions in platelets and smooth muscle. Ref.4 Ref.5 Ref.6 Ref.7 Ref.10 |
| Catalytic activity | ATP + a protein = ADP + a phosphoprotein. |
| Enzyme regulation | In the absence of cGMP, PRKG1 activity is suppressed by autoinhibitory contacts By similarity. |
| Subunit structure | Isoform alpha: parallel homodimer or heterodimer and also heterotetramer. Interacts directly with PPP1R12A. Non-covalent dimer of dimer of PRKG1-PRKG1 and PPP1R12A-PPP1R12A. This interaction targets PRKG1 to stress fibers to mediate smooth muscle cell relaxation and vasodilation in responses to rises in cGMP By similarity. Isoform beta: antiparallel homodimer. Part of cGMP kinase signaling complex at least composed of ACTA2/alpha-actin, CNN1/calponin H1, PLN/phospholamban, PRKG1 and ITPR1 By similarity. Interacts with MRVI1. Forms a stable complex with ITPR1, MRVI1, and isoform beta of PRKG1 By similarity. Interacts with TRPC7 (via ankyrin repeat domain) By similarity. Isoform alpha interacts with RGS2 By similarity. Interacts with GTF2I By similarity. Ref.9 |
| Subcellular location | Cytoplasm By similarity. Note: Colocalized with TRPC7 in the plasma membrane By similarity. |
| Tissue specificity | Detected in cerebellum, hippocampus, dorsomedial hypothalamus, medulla, subcommissural organ, cerebral cortex, amygdala, habenulae, various hypothalamic regions, olfactory bulb, pituitary gland, and retina. Isoform alpha is prominent in the cerebellum and medulla, whereas isoform Beta is predominant in the cortex, hippocampus, hypothalamus, and olfactory bulb. Ref.8 |
| Domain | Composed of an N-terminal leucine-zipper domain followed by an autoinhibitory domain, which mediate homodimer formation and inhibit kinase activity, respectively. Next, two cGMP-binding domains are followed by the catalytic domain at the C-terminus. Binding of cGMP to cGMP-binding domains results in a conformational change that activates kinase activity by removing the autoinhibitory domain from the catalytic cleft leaving the catalytic domain free to phosphorylate downstream substrates. Isoforms alpha and beta have identical cGMP-binding and catalytic domains but differ in their leucine zipper and autoinhibitory sequences and therefore differ in their dimerization substrates and kinase enzyme activity By similarity. Heterotetramerization is mediated by the interaction between a coiled-coil of PRKG1 and the leucine/isoleucine zipper of PPP1R12A/MBS, the myosin-binding subunit of the myosin phosphatase By similarity. |
| Post-translational modification | Autophosphorylation increases kinase activity By similarity. 65 kDa monomer is produced by proteolytic cleavage By similarity. |
| Disruption phenotype | Leads to premature death at approximately 6 weeks of age, presumably due to smooth muscle dysfunction. These mice show multiple defects including impaired smooth muscle relaxation, disturbed gastrointestinal motility and enhanced platelet adhesion. Ref.4 Ref.6 |
| Sequence similarities | Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. cGMP subfamily. Contains 1 AGC-kinase C-terminal domain. Contains 2 cyclic nucleotide-binding domains. Contains 1 protein kinase domain. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform Alpha (identifier: P0C605-1) Also known as: CGK1-alpha; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform Beta (identifier: P0C605-2) Also known as: CGK1-beta; The sequence of this isoform differs from the canonical sequence as follows: 1-89: MSELEEDFAK...AFRKFTKSER → MGTLRDLQYA...TLPFYPKSPQ |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed By similarity | ||||||
| Chain | 2 – 671 | 670 | cGMP-dependent protein kinase 1 | PRO_0000314022 | |||||
Regions | |||||||||
| Domain | 9 – 44 | 36 | Leucine-zipper | ||||||
| Domain | 360 – 619 | 260 | Protein kinase | ||||||
| Domain | 620 – 671 | 52 | AGC-kinase C-terminal | ||||||
| Nucleotide binding | 167 – 170 | 4 | cAMP or cGMP By similarity | ||||||
| Nucleotide binding | 177 – 178 | 2 | cAMP or cGMP By similarity | ||||||
| Nucleotide binding | 366 – 374 | 9 | ATP By similarity | ||||||
| Region | 2 – 102 | 101 | Required for dimerization By similarity | ||||||
| Region | 50 – 75 | 26 | Autoinhibitory domain By similarity | ||||||
| Region | 103 – 220 | 118 | cGMP-binding, high affinity By similarity | ||||||
| Region | 221 – 341 | 121 | cGMP-binding, low affinity By similarity | ||||||
Sites | |||||||||
| Active site | 484 | 1 | Proton acceptor By similarity | ||||||
| Binding site | 390 | 1 | ATP By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 2 | 1 | N-acetylserine By similarity | ||||||
| Modified residue | 59 | 1 | Phosphothreonine; by autocatalysis By similarity | ||||||
| Modified residue | 515 | 1 | Phosphothreonine By similarity | ||||||
| Disulfide bond | 43 | Interchain By similarity | |||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 89 | 89 | MSELE…TKSER → MGTLRDLQYALQEKIEELRQ RDALIDELELELDQKDELIQ KLQNELDKYRSVIRPATQQA QKQSASTLQGEPRTKRQAIS AEPTAFDIQDLSHVTLPFYP KSPQ in isoform Beta. | VSP_038715 | |||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cyclic AMP- and cyclic GMP-dependent protein kinases differ in their regulation of cyclic AMP response element-dependent gene transcription." Collins S.P., Uhler M.D. J. Biol. Chem. 274:8391-8404(1999) [PubMed: 10085070] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA). Strain: C57BL/6. Tissue: Brain. |
| [2] | "Lineage-specific biology revealed by a finished genome assembly of the mouse." Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S. Ponting C.P.PLoS Biol. 7:E1000112-E1000112(2009) [PubMed: 19468303] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. Strain: C57BL/6J. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BETA). |
| [4] | "Defective smooth muscle regulation in cGMP kinase I-deficient mice." Pfeifer A., Klatt P., Massberg S., Ny L., Sausbier M., Hirneiss C., Wang G.X., Korth M., Aszodi A., Andersson K.E., Krombach F., Mayerhofer A., Ruth P., Fassler R., Hofmann F. EMBO J. 17:3045-3051(1998) [PubMed: 9606187] [Abstract] Cited for: DISRUPTION PHENOTYPE, FUNCTION. |
| [5] | "Phosphorylation-dependent inhibition of protein phosphatase-1 by G-substrate: a Purkinje cell substrate of the cyclic GMP-dependent protein kinase." Hall K.U., Collins S.P., Gamm D.M., Massa E., Depaoli-Roach A.A., Uhler M.D. J. Biol. Chem. 274:3485-3495(1999) [PubMed: 9920894] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF PPP1R17. Tissue: Brain. |
| [6] | "Increased adhesion and aggregation of platelets lacking cyclic guanosine 3',5'-monophosphate kinase I." Massberg S., Sausbier M., Klatt P., Bauer M., Pfeifer A., Siess W., Fassler R., Ruth P., Krombach F., Hofmann F. J. Exp. Med. 189:1255-1264(1999) [PubMed: 10209042] [Abstract] Cited for: DISRUPTION PHENOTYPE, FUNCTION. |
| [7] | "Mechanisms of NO/cGMP-dependent vasorelaxation." Sausbier M., Schubert R., Voigt V., Hirneiss C., Pfeifer A., Korth M., Kleppisch T., Ruth P., Hofmann F. Circ. Res. 87:825-830(2000) [PubMed: 11055988] [Abstract] Cited for: FUNCTION IN THE REGULATION OF VASCULAR TONE. |
| [8] | "Distribution of cGMP-dependent protein kinase type I and its isoforms in the mouse brain and retina." Feil S., Zimmermann P., Knorn A., Brummer S., Schlossmann J., Hofmann F., Feil R. Neuroscience 135:863-868(2005) [PubMed: 16154279] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [9] | "IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation." Antl M., von Bruehl M.-L., Eiglsperger C., Werner M., Konrad I., Kocher T., Wilm M., Hofmann F., Massberg S., Schlossmann J. Blood 109:552-559(2007) [PubMed: 16990611] [Abstract] Cited for: INTERACTION WITH MRVI1. |
| [10] | "cGMP-dependent protein kinase type I is implicated in the regulation of the timing and quality of sleep and wakefulness." Langmesser S., Franken P., Feil S., Emmenegger Y., Albrecht U., Feil R. PLoS ONE 4:E4238-E4238(2009) [PubMed: 19156199] [Abstract] Cited for: FUNCTION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF084547 mRNA. Translation: AAD16044.1. AC102751 Genomic DNA. No translation available. AC103405 Genomic DNA. No translation available. AC108399 Genomic DNA. No translation available. AC116507 Genomic DNA. No translation available. AC119158 Genomic DNA. No translation available. AC122548 Genomic DNA. No translation available. BC113162 mRNA. Translation: AAI13163.1. |
| IPI | IPI00129693. IPI00458024. |
| RefSeq | NP_001013855.1. NM_001013833.3. NP_035290.1. NM_011160.3. |
| UniGene | Mm.381170. Mm.381172. |
3D structure databases | |
| ProteinModelPortal | P0C605. |
| SMR | P0C605. Positions 9-44, 79-658. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP-29981N. |
| STRING | P0C605. |
Proteomic databases | |
| PRIDE | P0C605. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000065067; ENSMUSP00000067576; ENSMUSG00000052920. ENSMUST00000073581; ENSMUSP00000073268; ENSMUSG00000052920. |
| GeneID | 19091. |
| KEGG | mmu:19091. |
| UCSC | uc008heo.1. mouse. |
Organism-specific databases | |
| CTD | 5592. |
| MGI | MGI:108174. Prkg1. |
Phylogenomic databases | |
| HOVERGEN | HBG006211. |
| OMA | HHIVETR. |
| OrthoDB | EOG4V9TQ7. |
| PhylomeDB | P0C605. |
Gene expression databases | |
| ArrayExpress | P0C605. |
| Bgee | P0C605. |
| CleanEx | MM_PRKG1. |
| Genevestigator | P0C605. |
Family and domain databases | |
| InterPro | IPR000961. AGC-kinase_C. IPR016232. cGMP-dependent_protein_kinase. IPR002374. cGMP_dep_kinase. IPR018490. cNMP-bd-like. IPR018488. cNMP-bd_CS. IPR000595. cNMP-bd_dom. IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR014710. RmlC-like_jellyroll. IPR017442. Se/Thr_kinase-like_dom. IPR008271. Ser/Thr_kinase_AS. IPR002290. Ser/Thr_kinase_dom. [Graphical view] |
| Gene3D | G3DSA:2.60.120.10. RmlC-like_jellyroll. 2 hits. |
| KO | K07376. |
| Pfam | PF00027. cNMP_binding. 2 hits. PF00069. Pkinase. 1 hit. [Graphical view] |
| PIRSF | PIRSF000559. cGMP-dep_kinase. 1 hit. |
| PRINTS | PR00104. CGMPKINASE. |
| SMART | SM00100. cNMP. 2 hits. SM00133. S_TK_X. 1 hit. SM00220. S_TKc. 1 hit. [Graphical view] |
| SUPFAM | SSF51206. cNMP_binding. 2 hits. SSF56112. Kinase_like. 1 hit. |
| PROSITE | PS51285. AGC_KINASE_CTER. 1 hit. PS00888. CNMP_BINDING_1. 2 hits. PS00889. CNMP_BINDING_2. 2 hits. PS50042. CNMP_BINDING_3. 2 hits. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 295648. |
| SOURCE | Search... |
Entry information
| Entry name | KGP1_MOUSE | ||||||||
| Accession | Primary (citable) accession number: P0C605 Secondary accession number(s): Q14DK6, Q9Z0Z0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with